331A — Medix Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Medix, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 637 | 788 | 952 | 662 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 147 | -30.6 | -131 | -4.3 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -297 | -123 | -366 | -466 |
| Change in Accounts Receivable | ||||
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 558 | 676 | 500 | 253 |
| Capital Expenditures | -44.8 | -44.1 | -17.2 | -38.5 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | 73.4 | 52.6 | 432 | -284 |
| Acquisition of Business | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | 28.7 | 8.51 | 414 | -322 |
| Financing Cash Flow Items | -28 | -45.5 | -0.001 | -0.002 |
| Other Financing Cash Flow | ||||
| Total Cash Dividends Paid | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -0.544 | -218 | 76.3 | 362 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 586 | 467 | 991 | 293 |